The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation

© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Powerful experimental tools have contributed a wealth of novel insight into cancer etiology from the organ to the subcellular levels. However, these advances in understanding have outpaced improvements in clinical outc...

Full description

Bibliographic Details
Main Authors: Coughlin, Mark F, Kamm, Roger D
Format: Article
Language:English
Published: Wiley 2021
Online Access:https://hdl.handle.net/1721.1/136279
_version_ 1826189804895731712
author Coughlin, Mark F
Kamm, Roger D
author_facet Coughlin, Mark F
Kamm, Roger D
author_sort Coughlin, Mark F
collection MIT
description © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Powerful experimental tools have contributed a wealth of novel insight into cancer etiology from the organ to the subcellular levels. However, these advances in understanding have outpaced improvements in clinical outcomes. One possible reason for this shortcoming is the reliance on animal models that do not fully replicate human physiology. An alternative in vitro approach that has recently emerged features engineered microfluidic platforms to investigate cancer progression. These devices allow precise control over cellular components, extracellular constituents, and physical forces, while facilitating detailed microscopic analysis of the metastatic process. This review focuses on the recent use of microfluidic platforms to investigate the mechanism of cancer cell extravasation.
first_indexed 2024-09-23T08:23:30Z
format Article
id mit-1721.1/136279
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T08:23:30Z
publishDate 2021
publisher Wiley
record_format dspace
spelling mit-1721.1/1362792021-10-28T04:58:35Z The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation Coughlin, Mark F Kamm, Roger D © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Powerful experimental tools have contributed a wealth of novel insight into cancer etiology from the organ to the subcellular levels. However, these advances in understanding have outpaced improvements in clinical outcomes. One possible reason for this shortcoming is the reliance on animal models that do not fully replicate human physiology. An alternative in vitro approach that has recently emerged features engineered microfluidic platforms to investigate cancer progression. These devices allow precise control over cellular components, extracellular constituents, and physical forces, while facilitating detailed microscopic analysis of the metastatic process. This review focuses on the recent use of microfluidic platforms to investigate the mechanism of cancer cell extravasation. 2021-10-27T20:34:41Z 2021-10-27T20:34:41Z 2020 2020-08-17T16:19:22Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/136279 en 10.1002/ADHM.201901410 Advanced Healthcare Materials Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf Wiley Wiley
spellingShingle Coughlin, Mark F
Kamm, Roger D
The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation
title The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation
title_full The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation
title_fullStr The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation
title_full_unstemmed The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation
title_short The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation
title_sort use of microfluidic platforms to probe the mechanism of cancer cell extravasation
url https://hdl.handle.net/1721.1/136279
work_keys_str_mv AT coughlinmarkf theuseofmicrofluidicplatformstoprobethemechanismofcancercellextravasation
AT kammrogerd theuseofmicrofluidicplatformstoprobethemechanismofcancercellextravasation
AT coughlinmarkf useofmicrofluidicplatformstoprobethemechanismofcancercellextravasation
AT kammrogerd useofmicrofluidicplatformstoprobethemechanismofcancercellextravasation